CVRx, Inc. Interest Expense Nonoperating
CVRx, Inc. (CVRX) reported Interest Expense Nonoperating of $1.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-06
- CVRx, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $1.58M, a 7.13% increase year-over-year.
- CVRx, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $1.55M, a 6.45% increase year-over-year.
- CVRx, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $1.42M, a 6.78% decline year-over-year.
- CVRx, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $1.48M, a 54.49% increase year-over-year.
- CVRx, Inc. interest expense nonoperating for fiscal 2025 was $5.83M, a 32.52% increase from fiscal 2024.
- CVRx, Inc. interest expense nonoperating for fiscal 2024 was $4.40M, a 144.41% increase from fiscal 2023.
- CVRx, Inc. interest expense nonoperating for fiscal 2023 was $1.80M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.58M 10-Q · filed 2026-08-06 | $3.13M 10-Q · filed 2026-08-06 | $4.55M derived: sum of 3 quarters · filed 2026-08-06 | $6.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.55M 10-Q · filed 2026-05-12 | $2.97M derived: sum of 2 quarters · filed 2026-05-12 | $4.45M derived: sum of 3 quarters · filed 2026-05-12 | $5.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.90M derived: sum of 2 quarters · filed 2026-02-13 | $4.37M derived: sum of 3 quarters · filed 2026-08-06 | $5.83M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.48M 10-Q · filed 2025-11-06 | $2.95M derived: sum of 2 quarters · filed 2026-08-06 | $4.41M 10-Q · filed 2025-11-06 | $5.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.47M 10-Q · filed 2026-08-06 | $2.93M 10-Q · filed 2026-08-06 | $4.45M derived: sum of 3 quarters · filed 2026-08-06 | $5.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.46M 10-Q · filed 2026-05-12 | $2.98M derived: sum of 2 quarters · filed 2026-05-12 | $3.94M derived: sum of 3 quarters · filed 2026-05-12 | $4.89M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.48M derived: sum of 2 quarters · filed 2026-02-13 | $3.44M derived: sum of 3 quarters · filed 2026-02-13 | $4.40M 10-K · filed 2026-02-13 |
| 2024-09-30 | $958.00K 10-Q · filed 2025-11-06 | $1.92M derived: sum of 2 quarters · filed 2025-11-06 | $2.88M 10-Q · filed 2025-11-06 | $3.46M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $959.00K 10-Q · filed 2025-08-05 | $1.92M 10-Q · filed 2025-08-05 | $2.50M derived: sum of 3 quarters · filed 2025-08-05 | $3.00M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $960.00K 10-Q · filed 2025-05-09 | $1.54M derived: sum of 2 quarters · filed 2025-05-09 | $2.04M derived: sum of 3 quarters · filed 2025-05-09 | $2.52M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.08M derived: sum of 2 quarters · filed 2025-02-18 | $1.56M derived: sum of 3 quarters · filed 2025-02-18 | $1.80M 10-K · filed 2025-02-18 |
| 2023-09-30 | $499.00K 10-Q · filed 2024-11-01 | $980.00K derived: sum of 2 quarters · filed 2024-11-01 | $1.22M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $481.00K 10-Q · filed 2024-08-02 | $721.00K 10-Q · filed 2024-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |